FDA Authorizes First Consumer Wearable Device for Continuous Ketone and Glucose Monitoring

In a historic regulatory decision for digital health, the FDA has granted clearance to the first consumer wearable sensor that continuously tracks both glucose and ketone levels.

Designed for individuals with diabetes and metabolic health conditions, the small arm patch provides early warning alerts for diabetic ketoacidosis (DKA) while streaming continuous metabolic trends to paired mobile devices.

Healthcare providers hail the dual-monitoring authorization as a landmark advancement for preventative patient care and metabolic management.